Cargando…
Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification o...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922508/ https://www.ncbi.nlm.nih.gov/pubmed/33669483 http://dx.doi.org/10.3390/cells10020438 |
_version_ | 1783658706275139584 |
---|---|
author | Harb, Jean Mennesson, Nicolas Lepetit, Cassandra Fourny, Maeva Louvois, Margaux Bosseboeuf, Adrien Allain-Maillet, Sophie Decaux, Olivier Moreau, Caroline Tallet, Anne Piver, Eric Moreau, Philippe Salle, Valéry Bigot-Corbel, Edith Hermouet, Sylvie |
author_facet | Harb, Jean Mennesson, Nicolas Lepetit, Cassandra Fourny, Maeva Louvois, Margaux Bosseboeuf, Adrien Allain-Maillet, Sophie Decaux, Olivier Moreau, Caroline Tallet, Anne Piver, Eric Moreau, Philippe Salle, Valéry Bigot-Corbel, Edith Hermouet, Sylvie |
author_sort | Harb, Jean |
collection | PubMed |
description | Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma. |
format | Online Article Text |
id | pubmed-7922508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79225082021-03-03 Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens Harb, Jean Mennesson, Nicolas Lepetit, Cassandra Fourny, Maeva Louvois, Margaux Bosseboeuf, Adrien Allain-Maillet, Sophie Decaux, Olivier Moreau, Caroline Tallet, Anne Piver, Eric Moreau, Philippe Salle, Valéry Bigot-Corbel, Edith Hermouet, Sylvie Cells Article Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma. MDPI 2021-02-19 /pmc/articles/PMC7922508/ /pubmed/33669483 http://dx.doi.org/10.3390/cells10020438 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Harb, Jean Mennesson, Nicolas Lepetit, Cassandra Fourny, Maeva Louvois, Margaux Bosseboeuf, Adrien Allain-Maillet, Sophie Decaux, Olivier Moreau, Caroline Tallet, Anne Piver, Eric Moreau, Philippe Salle, Valéry Bigot-Corbel, Edith Hermouet, Sylvie Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title | Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title_full | Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title_fullStr | Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title_full_unstemmed | Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title_short | Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens |
title_sort | comparison of monoclonal gammopathies linked to poliovirus or coxsackievirus vs. other infectious pathogens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922508/ https://www.ncbi.nlm.nih.gov/pubmed/33669483 http://dx.doi.org/10.3390/cells10020438 |
work_keys_str_mv | AT harbjean comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT mennessonnicolas comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT lepetitcassandra comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT fournymaeva comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT louvoismargaux comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT bosseboeufadrien comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT allainmailletsophie comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT decauxolivier comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT moreaucaroline comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT talletanne comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT pivereric comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT moreauphilippe comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT sallevalery comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT bigotcorbeledith comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens AT hermouetsylvie comparisonofmonoclonalgammopathieslinkedtopoliovirusorcoxsackievirusvsotherinfectiouspathogens |